Table of Contents

Global Chronic Myelogenous Leukemia Treatment Market Size, Status and Forecast 2025

1 Industry Overview of Chronic Myelogenous Leukemia Treatment

1.1 Chronic Myelogenous Leukemia Treatment Market Overview

1.1.1 Chronic Myelogenous Leukemia Treatment Product Scope

1.1.2 Market Status and Outlook

1.2 Global Chronic Myelogenous Leukemia Treatment Market Size and Analysis by Regions (2013-2018)

1.2.1 United States

1.2.2 EU

1.2.3 Japan

1.2.4 China

1.2.5 India

1.2.6 Southeast Asia

1.3 Chronic Myelogenous Leukemia Treatment Market by Type

1.3.1 Disease Specific Treatment

1.3.2 Symptomatic Treatment

1.4 Chronic Myelogenous Leukemia Treatment Market by End Users/Application

1.4.1 Hospital Pharmacies

1.4.2 Specialty Pharmacies

1.4.3 Retail Pharmacies

2 Global Chronic Myelogenous Leukemia Treatment Competition Analysis by Players

2.1 Chronic Myelogenous Leukemia Treatment Market Size (Value) by Players (2013-2018)

2.2 Competitive Status and Trend

2.2.1 Market Concentration Rate

2.2.2 Product/Service Differences

2.2.3 New Entrants

2.2.4 The Technology Trends in Future

3 Company (Top Players) Profiles

3.1 Bristol-Myers Squibb

3.1.1 Company Profile

3.1.2 Main Business/Business Overview

3.1.3 Products, Services and Solutions

3.1.4 Chronic Myelogenous Leukemia Treatment Revenue (Million USD) (2013-2018)

3.1.5 Recent Developments

3.2 Novartis AG

3.2.1 Company Profile

3.2.2 Main Business/Business Overview

3.2.3 Products, Services and Solutions

3.2.4 Chronic Myelogenous Leukemia Treatment Revenue (Million USD) (2013-2018)

3.2.5 Recent Developments

3.3 Pfizer Inc.

3.3.1 Company Profile

3.3.2 Main Business/Business Overview

3.3.3 Products, Services and Solutions

3.3.4 Chronic Myelogenous Leukemia Treatment Revenue (Million USD) (2013-2018)

3.3.5 Recent Developments

3.4 Teva Pharmaceuticals

3.4.1 Company Profile

3.4.2 Main Business/Business Overview

3.4.3 Products, Services and Solutions

3.4.4 Chronic Myelogenous Leukemia Treatment Revenue (Million USD) (2013-2018)

3.4.5 Recent Developments

3.5 Roche Holdings AG

3.5.1 Company Profile

3.5.2 Main Business/Business Overview

3.5.3 Products, Services and Solutions

3.5.4 Chronic Myelogenous Leukemia Treatment Revenue (Million USD) (2013-2018)

3.5.5 Recent Developments

3.6 Incyte Corporation

3.6.1 Company Profile

3.6.2 Main Business/Business Overview

3.6.3 Products, Services and Solutions

3.6.4 Chronic Myelogenous Leukemia Treatment Revenue (Million USD) (2013-2018)

3.6.5 Recent Developments

3.7 Bio-Path Holdings

3.7.1 Company Profile

3.7.2 Main Business/Business Overview

3.7.3 Products, Services and Solutions

3.7.4 Chronic Myelogenous Leukemia Treatment Revenue (Million USD) (2013-2018)

3.7.5 Recent Developments

4 Global Chronic Myelogenous Leukemia Treatment Market Size by Type and Application (2013-2018)

4.1 Global Chronic Myelogenous Leukemia Treatment Market Size by Type (2013-2018)

4.2 Global Chronic Myelogenous Leukemia Treatment Market Size by Application (2013-2018)

4.3 Potential Application of Chronic Myelogenous Leukemia Treatment in Future

4.4 Top Consumer/End Users of Chronic Myelogenous Leukemia Treatment

5 United States Chronic Myelogenous Leukemia Treatment Development Status and Outlook

5.1 United States Chronic Myelogenous Leukemia Treatment Market Size (2013-2018)

5.2 United States Chronic Myelogenous Leukemia Treatment Market Size and Market Share by Players (2013-2018)

5.3 United States Chronic Myelogenous Leukemia Treatment Market Size by Application (2013-2018)

6 EU Chronic Myelogenous Leukemia Treatment Development Status and Outlook

6.1 EU Chronic Myelogenous Leukemia Treatment Market Size (2013-2018)

6.2 EU Chronic Myelogenous Leukemia Treatment Market Size and Market Share by Players (2013-2018)

6.3 EU Chronic Myelogenous Leukemia Treatment Market Size by Application (2013-2018)

7 Japan Chronic Myelogenous Leukemia Treatment Development Status and Outlook

7.1 Japan Chronic Myelogenous Leukemia Treatment Market Size (2013-2018)

7.2 Japan Chronic Myelogenous Leukemia Treatment Market Size and Market Share by Players (2013-2018)

7.3 Japan Chronic Myelogenous Leukemia Treatment Market Size by Application (2013-2018)

8 China Chronic Myelogenous Leukemia Treatment Development Status and Outlook

8.1 China Chronic Myelogenous Leukemia Treatment Market Size (2013-2018)

8.2 China Chronic Myelogenous Leukemia Treatment Market Size and Market Share by Players (2013-2018)

8.3 China Chronic Myelogenous Leukemia Treatment Market Size by Application (2013-2018)

9 India Chronic Myelogenous Leukemia Treatment Development Status and Outlook

9.1 India Chronic Myelogenous Leukemia Treatment Market Size (2013-2018)

9.2 India Chronic Myelogenous Leukemia Treatment Market Size and Market Share by Players (2013-2018)

9.3 India Chronic Myelogenous Leukemia Treatment Market Size by Application (2013-2018)

10 Southeast Asia Chronic Myelogenous Leukemia Treatment Development Status and Outlook

10.1 Southeast Asia Chronic Myelogenous Leukemia Treatment Market Size (2013-2018)

10.2 Southeast Asia Chronic Myelogenous Leukemia Treatment Market Size and Market Share by Players (2013-2018)

10.3 Southeast Asia Chronic Myelogenous Leukemia Treatment Market Size by Application (2013-2018)

11 Market Forecast by Regions, Type and Application (2018-2025)

11.1 Global Chronic Myelogenous Leukemia Treatment Market Size (Value) by Regions (2018-2025)

11.1.1 United States Chronic Myelogenous Leukemia Treatment Revenue and Growth Rate (2018-2025)

11.1.2 EU Chronic Myelogenous Leukemia Treatment Revenue and Growth Rate (2018-2025)

11.1.3 Japan Chronic Myelogenous Leukemia Treatment Revenue and Growth Rate (2018-2025)

11.1.4 China Chronic Myelogenous Leukemia Treatment Revenue and Growth Rate (2018-2025)

11.1.5 India Chronic Myelogenous Leukemia Treatment Revenue and Growth Rate (2018-2025)

11.1.6 Southeast Asia Chronic Myelogenous Leukemia Treatment Revenue and Growth Rate (2018-2025)

11.2 Global Chronic Myelogenous Leukemia Treatment Market Size (Value) by Type (2018-2025)

11.3 Global Chronic Myelogenous Leukemia Treatment Market Size by Application (2018-2025)

12 Chronic Myelogenous Leukemia Treatment Market Dynamics

12.1 Chronic Myelogenous Leukemia Treatment Market Opportunities

12.2 Chronic Myelogenous Leukemia Treatment Challenge and Risk

12.2.1 Competition from Opponents

12.2.2 Downside Risks of Economy

12.3 Chronic Myelogenous Leukemia Treatment Market Constraints and Threat

12.3.1 Threat from Substitute

12.3.2 Government Policy

12.3.3 Technology Risks

12.4 Chronic Myelogenous Leukemia Treatment Market Driving Force

12.4.1 Growing Demand from Emerging Markets

12.4.2 Potential Application

13 Market Effect Factors Analysis

13.1 Technology Progress/Risk

13.1.1 Substitutes

13.1.2 Technology Progress in Related Industry

13.2 Consumer Needs Trend/Customer Preference

13.3 External Environmental Change

13.3.1 Economic Fluctuations

13.3.2 Other Risk Factors

14 Research Finding/Conclusion

15 Appendix

Methodology

Analyst Introduction

Data Source

List of Tables and Figures

Figure Global Chronic Myelogenous Leukemia Treatment Market Size (Million USD) Status and Outlook (2013-2018)

Table Global Chronic Myelogenous Leukemia Treatment Revenue (Million USD) Comparison by Regions (2013-2018)

Figure Global Chronic Myelogenous Leukemia Treatment Market Share by Regions (2013-2018)

Figure United States Chronic Myelogenous Leukemia Treatment Market Size (Million USD) and Growth Rate by Regions (2013-2018)

Figure EU Chronic Myelogenous Leukemia Treatment Market Size (Million USD) and Growth Rate by Regions (2013-2018)

Figure Japan Chronic Myelogenous Leukemia Treatment Market Size (Million USD) and Growth Rate by Regions (2013-2018)

Figure China Chronic Myelogenous Leukemia Treatment Market Size (Million USD) and Growth Rate by Regions (2013-2018)

Figure India Chronic Myelogenous Leukemia Treatment Market Size (Million USD) and Growth Rate by Regions (2013-2018)

Figure Southeast Asia Chronic Myelogenous Leukemia Treatment Market Size (Million USD) and Growth Rate by Regions (2013-2018)

Table Global Chronic Myelogenous Leukemia Treatment Revenue (Million USD) and Growth Rate (%) Comparison by Product (2013-2018)

Figure Global Chronic Myelogenous Leukemia Treatment Revenue Market Share by Type in 2017

Figure Disease Specific Treatment Market Size (Million USD) and Growth Rate (2013-2018)

Figure Symptomatic Treatment Market Size (Million USD) and Growth Rate (2013-2018)

Figure Global Chronic Myelogenous Leukemia Treatment Market Share by Application in 2017

Figure Chronic Myelogenous Leukemia Treatment Market Size (Million USD) and Growth Rate in Hospital Pharmacies (2013-2018)

Figure Chronic Myelogenous Leukemia Treatment Market Size (Million USD) and Growth Rate in Specialty Pharmacies (2013-2018)

Figure Chronic Myelogenous Leukemia Treatment Market Size (Million USD) and Growth Rate in Retail Pharmacies (2013-2018)

Table Chronic Myelogenous Leukemia Treatment Market Size (Million USD) by Players (2013-2018)

Figure Chronic Myelogenous Leukemia Treatment Market Size Share by Players in 2013

Figure Chronic Myelogenous Leukemia Treatment Market Size Share by Players in 2017

Table Bristol-Myers Squibb Basic Information List

Table Chronic Myelogenous Leukemia Treatment Business Revenue (Million USD) of Bristol-Myers Squibb (2013-2018)

Figure Bristol-Myers Squibb Chronic Myelogenous Leukemia Treatment Business Revenue Market Share (2013-2018)

Table Novartis AG Basic Information List

Table Chronic Myelogenous Leukemia Treatment Business Revenue (Million USD) of Novartis AG (2013-2018)

Figure Novartis AG Chronic Myelogenous Leukemia Treatment Business Revenue Market Share (2013-2018)

Table Pfizer Inc. Basic Information List

Table Chronic Myelogenous Leukemia Treatment Business Revenue (Million USD) of Pfizer Inc. (2013-2018)

Figure Pfizer Inc. Chronic Myelogenous Leukemia Treatment Business Revenue Market Share (2013-2018)

Table Teva Pharmaceuticals Basic Information List

Table Chronic Myelogenous Leukemia Treatment Business Revenue (Million USD) of Teva Pharmaceuticals (2013-2018)

Figure Teva Pharmaceuticals Chronic Myelogenous Leukemia Treatment Business Revenue Market Share (2013-2018)

Table Roche Holdings AG Basic Information List

Table Chronic Myelogenous Leukemia Treatment Business Revenue (Million USD) of Roche Holdings AG (2013-2018)

Figure Roche Holdings AG Chronic Myelogenous Leukemia Treatment Business Revenue Market Share (2013-2018)

Table Incyte Corporation Basic Information List

Table Chronic Myelogenous Leukemia Treatment Business Revenue (Million USD) of Incyte Corporation (2013-2018)

Figure Incyte Corporation Chronic Myelogenous Leukemia Treatment Business Revenue Market Share (2013-2018)

Table Bio-Path Holdings Basic Information List

Table Chronic Myelogenous Leukemia Treatment Business Revenue (Million USD) of Bio-Path Holdings (2013-2018)

Figure Bio-Path Holdings Chronic Myelogenous Leukemia Treatment Business Revenue Market Share (2013-2018)

Table Global Chronic Myelogenous Leukemia Treatment Market Size (Million USD) by Product (2013-2018)

Figure Global Chronic Myelogenous Leukemia Treatment Revenue Market Share (%) by Product (2013-2018)

Figure Global Chronic Myelogenous Leukemia Treatment Market Share by Product in 2017

Table Global Chronic Myelogenous Leukemia Treatment Market Size by Application (2013-2018)

Figure Global Chronic Myelogenous Leukemia Treatment Revenue Market Share (%) by Application in 2017

Table Top Consumer/End Users of Chronic Myelogenous Leukemia Treatment

Figure United States Chronic Myelogenous Leukemia Treatment Market Size (Million USD) and Growth Rate (2013-2018)

Table United States Chronic Myelogenous Leukemia Treatment Market Size (Million USD) by Players (2013-2018)

Figure United States Chronic Myelogenous Leukemia Treatment Market Size Share by Players in 2013

Figure United States Chronic Myelogenous Leukemia Treatment Market Size Share by Players in 2017

Table United States Chronic Myelogenous Leukemia Treatment Market Size by Application (2013-2018)

Figure United States Chronic Myelogenous Leukemia Treatment Revenue Market Share (%) by Application (2013-2018)

Figure United States Chronic Myelogenous Leukemia Treatment Market Size Share by Application in 2017

Figure EU Chronic Myelogenous Leukemia Treatment Market Size (Million USD) and Growth Rate (2013-2018)

Table EU Chronic Myelogenous Leukemia Treatment Market Size (Million USD) by Players (2013-2018)

Figure EU Chronic Myelogenous Leukemia Treatment Market Size Share by Players in 2013

Figure EU Chronic Myelogenous Leukemia Treatment Market Size Share by Players in 2017

Table EU Chronic Myelogenous Leukemia Treatment Market Size by Application (2013-2018)

Figure EU Chronic Myelogenous Leukemia Treatment Revenue Market Share (%) by Application (2013-2018)

Figure EU Chronic Myelogenous Leukemia Treatment Market Size Share by Application in 2017

Figure Japan Chronic Myelogenous Leukemia Treatment Market Size (Million USD) and Growth Rate (2013-2018)

Table Japan Chronic Myelogenous Leukemia Treatment Market Size (Million USD) by Players (2013-2018)

Figure Japan Chronic Myelogenous Leukemia Treatment Market Size Share by Players in 2013

Figure Japan Chronic Myelogenous Leukemia Treatment Market Size Share by Players in 2017

Table Japan Chronic Myelogenous Leukemia Treatment Market Size by Application (2013-2018)

Figure Japan Chronic Myelogenous Leukemia Treatment Revenue Market Share (%) by Application (2013-2018)

Figure Japan Chronic Myelogenous Leukemia Treatment Market Size Share by Application in 2017

Figure China Chronic Myelogenous Leukemia Treatment Market Size (Million USD) and Growth Rate (2013-2018)

Table China Chronic Myelogenous Leukemia Treatment Market Size (Million USD) by Players (2013-2018)

Figure China Chronic Myelogenous Leukemia Treatment Market Size Share by Players in 2013

Figure China Chronic Myelogenous Leukemia Treatment Market Size Share by Players in 2017

Table China Chronic Myelogenous Leukemia Treatment Market Size by Application (2013-2018)

Figure China Chronic Myelogenous Leukemia Treatment Revenue Market Share (%) by Application (2013-2018)

Figure China Chronic Myelogenous Leukemia Treatment Market Size Share by Application in 2017

Figure India Chronic Myelogenous Leukemia Treatment Market Size (Million USD) and Growth Rate (2013-2018)

Table India Chronic Myelogenous Leukemia Treatment Market Size (Million USD) by Players (2013-2018)

Figure India Chronic Myelogenous Leukemia Treatment Market Size Share by Players in 2013

Figure India Chronic Myelogenous Leukemia Treatment Market Size Share by Players in 2017

Table India Chronic Myelogenous Leukemia Treatment Market Size by Application (2013-2018)

Figure India Chronic Myelogenous Leukemia Treatment Revenue Market Share (%) by Application (2013-2018)

Figure India Chronic Myelogenous Leukemia Treatment Market Size Share by Application in 2017

Figure Southeast Asia Chronic Myelogenous Leukemia Treatment Market Size (Million USD) and Growth Rate (2013-2018)

Table Southeast Asia Chronic Myelogenous Leukemia Treatment Market Size (Million USD) by Players (2013-2018)

Figure Southeast Asia Chronic Myelogenous Leukemia Treatment Market Size Share by Players in 2013

Figure Southeast Asia Chronic Myelogenous Leukemia Treatment Market Size Share by Players in 2017

Table Southeast Asia Chronic Myelogenous Leukemia Treatment Market Size by Application (2013-2018)

Figure Southeast Asia Chronic Myelogenous Leukemia Treatment Revenue Market Share (%) by Application (2013-2018)

Figure Southeast Asia Chronic Myelogenous Leukemia Treatment Market Size Share by Application in 2017

Figure Global Chronic Myelogenous Leukemia Treatment Market Size and Growth Rate (2018-2025)

Table Global Chronic Myelogenous Leukemia Treatment Market Size (Million USD) by Regions (2018-2025)

Figure Global Chronic Myelogenous Leukemia Treatment Market Size Share (2018-2025)

Figure Global Chronic Myelogenous Leukemia Treatment Market Size Share by Regions in 2025

Figure United States Chronic Myelogenous Leukemia Treatment Revenue (Million USD) and Growth Rate (2018-2025)

Figure EU Chronic Myelogenous Leukemia Treatment Revenue (Million USD) and Growth Rate (2018-2025)

Figure Japan Chronic Myelogenous Leukemia Treatment Revenue (Million USD) and Growth Rate (2018-2025)

Figure China Chronic Myelogenous Leukemia Treatment Revenue (Million USD) and Growth Rate (2018-2025)

Figure India Chronic Myelogenous Leukemia Treatment Revenue (Million USD) and Growth Rate (2018-2025)

Figure Southeast Asia Chronic Myelogenous Leukemia Treatment Revenue (Million USD) and Growth Rate (2018-2025)

Table Global Chronic Myelogenous Leukemia Treatment Market Size (Million USD) by Type (2018-2025)

Figure Global Chronic Myelogenous Leukemia Treatment Market Size Share by Type in 2018

Figure Global Chronic Myelogenous Leukemia Treatment Market Size Share by Type in 2025

Table Global Chronic Myelogenous Leukemia Treatment Market Size (Million USD) by Application (2018-2025)

Figure Global Chronic Myelogenous Leukemia Treatment Market Size (Million USD) by Application in 2018

Figure Global Chronic Myelogenous Leukemia Treatment Market Size (Million USD) by Application in 2025